1. Home
  2. Pharma & Healthcare
  3. Global PARP Inhibitor Biomarkers Service Market Status and Forecast 2021-2027

Global PARP Inhibitor Biomarkers Service Market Status and Forecast 2021-2027

Publication Month: Sep 2021 | No. of Pages: 116 Published By: GRD Survey
Single User License: US $ 2980
Corporate User License: US $ 5960

This report provides a comprehensive analysis of current global PARP Inhibitor Biomarkers Service market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the PARP Inhibitor Biomarkers Service industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global PARP Inhibitor Biomarkers Service market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global PARP Inhibitor Biomarkers Service Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global PARP Inhibitor Biomarkers Service market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global PARP Inhibitor Biomarkers Service Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global PARP Inhibitor Biomarkers Service industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions

Segmented by Type
BRCA 1 & 2 Testing
HRD Testing
HRR Testing
Others

Segmented by Application
Hospital
Clinic
Others

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
NeoGenomics Laboratories, Inc.
Myriad Genetics, Inc.
Invitae Corporation
Hoffmann-La Roche AG
BPS Bioscience, Inc.


Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global PARP Inhibitor Biomarkers Service Market Status and Forecast (2016-2027)
1.3.2 Global PARP Inhibitor Biomarkers Service Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global PARP Inhibitor Biomarkers Service Supply by Company
2.1 Global PARP Inhibitor Biomarkers Service Sales Value by Company
2.2 PARP Inhibitor Biomarkers Service Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional PARP Inhibitor Biomarkers Service Market Status by Type
3.1 PARP Inhibitor Biomarkers Service Type Introduction
3.1.1 BRCA 1 & 2 Testing
3.1.2 HRD Testing
3.1.3 HRR Testing
3.1.4 Others
3.2 Global PARP Inhibitor Biomarkers Service Market by Type
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional PARP Inhibitor Biomarkers Service Market Status by Application
4.1 PARP Inhibitor Biomarkers Service Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global PARP Inhibitor Biomarkers Service Market by Application
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global PARP Inhibitor Biomarkers Service Market Status by Region
5.1 Global PARP Inhibitor Biomarkers Service Market by Region
5.2 North America PARP Inhibitor Biomarkers Service Market Status
5.3 Europe PARP Inhibitor Biomarkers Service Market Status
5.4 Asia Pacific PARP Inhibitor Biomarkers Service Market Status
5.5 Central & South America PARP Inhibitor Biomarkers Service Market Status
5.6 Middle East & Africa PARP Inhibitor Biomarkers Service Market Status
6 North America PARP Inhibitor Biomarkers Service Market Status
6.1 North America PARP Inhibitor Biomarkers Service Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe PARP Inhibitor Biomarkers Service Market Status
7.1 Europe PARP Inhibitor Biomarkers Service Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific PARP Inhibitor Biomarkers Service Market Status
8.1 Asia Pacific PARP Inhibitor Biomarkers Service Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America PARP Inhibitor Biomarkers Service Market Status
9.1 Central & South America PARP Inhibitor Biomarkers Service Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa PARP Inhibitor Biomarkers Service Market Status
10.1 Middle East & Africa PARP Inhibitor Biomarkers Service Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global PARP Inhibitor Biomarkers Service Market Forecast by Type and by Application
12.1 Global PARP Inhibitor Biomarkers Service Sales Value Forecast (2022-2027)
12.2 Global PARP Inhibitor Biomarkers Service Forecast by Type
12.3 Global PARP Inhibitor Biomarkers Service Forecast by Application
13 Global PARP Inhibitor Biomarkers Service Market Forecast by Region/Country
13.1 Global PARP Inhibitor Biomarkers Service Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 NeoGenomics Laboratories, Inc.
14.1.1 Company Information
14.1.2 PARP Inhibitor Biomarkers Service Product Introduction
14.1.3 NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Service Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 Myriad Genetics, Inc.
14.2.1 Company Information
14.2.2 PARP Inhibitor Biomarkers Service Product Introduction
14.2.3 Myriad Genetics, Inc. PARP Inhibitor Biomarkers Service Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 Invitae Corporation
14.3.1 Company Information
14.3.2 PARP Inhibitor Biomarkers Service Product Introduction
14.3.3 Invitae Corporation PARP Inhibitor Biomarkers Service Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 Hoffmann-La Roche AG
14.4.1 Company Information
14.4.2 PARP Inhibitor Biomarkers Service Product Introduction
14.4.3 Hoffmann-La Roche AG PARP Inhibitor Biomarkers Service Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 BPS Bioscience, Inc.
14.5.1 Company Information
14.5.2 PARP Inhibitor Biomarkers Service Product Introduction
14.5.3 BPS Bioscience, Inc. PARP Inhibitor Biomarkers Service Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
...
15 Conclusion
16 Methodology

Tables and Figures

List of Tables

Table Global PARP Inhibitor Biomarkers Service Sales Value (Million USD) and CAGR by Region (2016-2027)
Table Global PARP Inhibitor Biomarkers Service Sales Value (Million USD) by Company (2019-2021)
Table Global PARP Inhibitor Biomarkers Service Sales Value Market Share by Company (2019-2021)
Table Main Manufacturers PARP Inhibitor Biomarkers Service Sales Area
Table PARP Inhibitor Biomarkers Service Market Concentration (Top 3, Top 5) (2019-2021)
Table Global PARP Inhibitor Biomarkers Service Sales Value (Million USD) by Type (2016-2021)
Table Global PARP Inhibitor Biomarkers Service Sals Value Market Share by Type (2016-2021)
Table North America PARP Inhibitor Biomarkers Service Sales Value (Million USD) by Type (2016-2021)
Table North America PARP Inhibitor Biomarkers Service Sales Value Market Share by Type (2016-2021)
Table Europe PARP Inhibitor Biomarkers Service Sales Value (Million USD) by Type (2016-2021)
Table Europe PARP Inhibitor Biomarkers Service Sales Value Market Share by Type (2016-2021)
Table Asia Pacific PARP Inhibitor Biomarkers Service Sales Value (Million USD) by Type (2016-2021)
Table Asia Pacific PARP Inhibitor Biomarkers Service Sales Value Market Share by Type (2016-2021)
Table Central & South America PARP Inhibitor Biomarkers Service Sales Value (Million USD) by Type (2016-2021)
Table Central & South America Pacific PARP Inhibitor Biomarkers Service Sales Value Market Share by Type (2016-2021)
Table Middle East & Africa PARP Inhibitor Biomarkers Service Sales Value (Million USD) by Type (2016-2021)
Table Middle East & Africa PARP Inhibitor Biomarkers Service Sales Value Market Share by Type (2016-2021)
Table Global PARP Inhibitor Biomarkers Service Sales Value (Million USD) by Application (2016-2021)
Table Global PARP Inhibitor Biomarkers Service Value Market Share by Application (2016-2021)
Table North America PARP Inhibitor Biomarkers Service Sales Value (Million USD) by Application (2016-2021)
Table North America PARP Inhibitor Biomarkers Service Sales Value Market Share by Application (2016-2021)
Table Europe PARP Inhibitor Biomarkers Service Sales Value (Million USD) by Application (2016-2021)
Table Europe PARP Inhibitor Biomarkers Service Sales Value Market Share by Application (2016-2021)
Table Asia Pacific PARP Inhibitor Biomarkers Service Sales Value (Million USD) by Application (2016-2021)
Table Asia Pacific PARP Inhibitor Biomarkers Service Sales Value Market Share by Application (2016-2021)
Table Central & South America PARP Inhibitor Biomarkers Service Sales Value (Million USD) by Application (2016-2021)
Table Central & South America Pacific PARP Inhibitor Biomarkers Service Sales Value Market Share by Application (2016-2021)
Table Middle East & Africa PARP Inhibitor Biomarkers Service Sales Value (Million USD) by Application (2016-2021)
Table Middle East & Africa PARP Inhibitor Biomarkers Service Sales Value Market Share by Application (2016-2021)
Table Global PARP Inhibitor Biomarkers Service Sales Value (Million USD) by Region (2016-2021)
Table Global PARP Inhibitor Biomarkers Service Value Market Share by Region (2016-2021)
Table North America PARP Inhibitor Biomarkers Service Sales Value (Million USD) by Country (2016-2021)
Table North America PARP Inhibitor Biomarkers Service Value Market Share by Country (2016-2021)
Table Europe PARP Inhibitor Biomarkers Service Sales Value (Million USD) by Country (2016-2021)
Table Europe PARP Inhibitor Biomarkers Service Value Market Share by Country (2016-2021)
Table Asia Pacific PARP Inhibitor Biomarkers Service Sales Value (Million USD) by Country (2016-2021)
Table Asia Pacific PARP Inhibitor Biomarkers Service Value Market Share by Country (2016-2021)
Table Central & South America PARP Inhibitor Biomarkers Service Sales Value (Million USD) by Country (2016-2021)
Table Central & South America PARP Inhibitor Biomarkers Service Value Market Share by Country (2016-2021)
Table Middle East & Africa PARP Inhibitor Biomarkers Service Sales Value (Million USD) by Country (2016-2021)
Table Middle East & Africa PARP Inhibitor Biomarkers Service Value Market Share by Country (2016-2021)
Table Global PARP Inhibitor Biomarkers Service Value (Million USD) Forecast by Type (2022-2027)
Table Global PARP Inhibitor Biomarkers Service Value Market Share Forecast by Type (2022-2027)
Table Global PARP Inhibitor Biomarkers Service Value (Million USD) Forecast by Application (2022-2027)
Table Global PARP Inhibitor Biomarkers Service Value Market Share Forecast by Application (2022-2027)
Table Global PARP Inhibitor Biomarkers Service Value (Million USD) Forecast by Region (2022-2027)
Table Global PARP Inhibitor Biomarkers Service Value Market Share Forecast by Region (2022-2027)
Table NeoGenomics Laboratories, Inc. Company Information
Table NeoGenomics Laboratories, Inc. Product Introduction
Table NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Service Sales Value, Gross Margin and Global Share (2019-2021)
Table Myriad Genetics, Inc. Company Information
Table Myriad Genetics, Inc. Product Introduction
Table Myriad Genetics, Inc. PARP Inhibitor Biomarkers Service Sales Value, Gross Margin and Global Share (2019-2021)
Table Invitae Corporation Company Information
Table Invitae Corporation Product Introduction
Table Invitae Corporation PARP Inhibitor Biomarkers Service Sales Value, Gross Margin and Global Share (2019-2021)
Table Hoffmann-La Roche AG Company Information
Table Hoffmann-La Roche AG Product Introduction
Table Hoffmann-La Roche AG PARP Inhibitor Biomarkers Service Sales Value, Gross Margin and Global Share (2019-2021)
Table BPS Bioscience, Inc. Company Information
Table BPS Bioscience, Inc. Product Introduction
Table BPS Bioscience, Inc. PARP Inhibitor Biomarkers Service Sales Value, Gross Margin and Global Share (2019-2021)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets